Moderna Inc (NASDAQ:MRNA)

98.63
Delayed Data
As of Nov 24
 -2.40 / -2.38%
Today’s Change
17.68
Today|||52-Week Range
103.20
+404.24%
Year-to-Date
ETFs to Play as Vaccine News Looks to Outdo Virus Fear
Nov 24 / Zacks.com - Paid Partner Content
Sanofi's (SNY) Meningitis Vaccine MenQuadfi Wins EU Approval
Nov 24 / Zacks.com - Paid Partner Content
Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU
Nov 24 / MotleyFool.com - Paid Partner Content
3 Coronavirus Vaccine Makers Near Finish Line in November
Nov 24 / Zacks.com - Paid Partner Content
Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism
Nov 24 / Zacks.com - Paid Partner Content
Celebrate Thanksgiving Week With These ETFs
Nov 24 / Zacks.com - Paid Partner Content
How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?
Nov 24 / Zacks.com - Paid Partner Content
5 Top-Performing Leveraged ETF Areas of Last Week
Nov 24 / Zacks.com - Paid Partner Content
5 ETFs That Gained in Double Digits Last Week
Nov 24 / Zacks.com - Paid Partner Content
Coronavirus Vaccine Stocks: Is There Room For Multiple Winners?
Nov 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close101.03
Today’s open98.25
Day’s range93.57 - 99.87
Volume348,053
Average volume (3 months)13,670,799
Market cap$38.6B
Data as of 5:30pm ET, 11/24/2020

Growth & Valuation

Earnings growth (last year)+68.63%
Earnings growth (this year)-17.60%
Earnings growth (next 5 years)+33.60%
Revenue growth (last year)-55.42%
P/E ratioNM
Price/Sales107.47
Price/Book27.96

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-0.74-0.30%
ILMNIllumina Inc+3.81+1.26%
----
EXASExact Sciences Corp-3.28-2.72%
Data as of 4:36pm ET, 11/24/2020

Financials

Next reporting dateMarch 10, 2021
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$60.2M
Annual profit (last year)-$514.0M
Net profit margin-853.73%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts